Angiotensinogen (1-14) (human) (trifluoroacetate salt)
|
- $54
- Product name: Angiotensinogen (1-14) (human) (trifluoroacetate salt)
- CAS:
- MF: C85H123F3N24O21
- MW: 1874.0295296
- EINECS:
- MDL Number:
- Synonyms:Angiotensinogen (1-14) (human) (trifluoroacetate salt)
1 prices
Selected condition：
Brand
- Cayman Chemical
Package
- 1mg
- ManufacturerCayman Chemical
- Product number24989
- Product descriptionAngiotensinogen (1-14) (human) (trifluoroacetate salt) ≥95%
- Packaging1mg
- Price$54
- Updated2026-04-30
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Cayman Chemical | 24989 | Angiotensinogen (1-14) (human) (trifluoroacetate salt) ≥95% | 1mg | $54 | 2026-04-30 | Buy |
Properties
solubility :Formic Acid: 1 mg/ml
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
Description
Angiotensinogen (1-14), also known as tetradecapeptide (TDP), is a synthetic peptide precursor of angiotensin I (Item No. 24737) that corresponds to amino acids 1-14 of endogenous human angiotensinogen.1 Angiotensinogen (1-14) is cleaved by renin at the Leu-Val peptide bond to release angiotensin I, which is then converted to angiotensin II (Item No. 17150) by angiotensin converting enzyme (ACE) and exerts vasoconstrictive properties.2 Angiotensinogen (1-14) (0.001-1 μM) induces contraction of isolated rat femoral resistance vessels, an effect that is reduced by the angiotensin II receptor partial antagonist saralasin and enhanced by the serine protease kallikrein.3WARNING This product is not for human or veterinary use.More related product prices